HAVCR2 and breast cancer: Saleh et al. reported that the co-inhibition of PD-1 and PD-L1 further upregulated LAG-3 and TIM-3 in T-cells and Tregs when co-cultured with TNBC cells, but not with other breast cancer cell lines [64].